23andMe just ... s Class B common stock. Prior to Google’s investment in 23andMe, Sergey provided approximately $2.6 million in interim debt financing to 23andMe, which was repaid as part of this financing transaction. Genentech’s Chief …
"Patient safety is of the utmost importance to Genentech, and we are working as fast as we can to address the temporary stock out of Boniva injection," said Christopher Vancheri, Genentech spokesman. He said the company expects to …
BRUSSELS (dpa-AFX) - The Swiss stock market ended Tuesday's session with a significant ... Roche finished down by 1.9 percent. Roche's Genentech subsidiary posted positive study results on cancer treatment TECENTRIQ. Swisscom …
First Roche decides to try and pick up the part of Genentech it doesn’t already own for a whopping ... Brocade will pay a combination of $18.50 of cash plus 0.0907 shares of Brocade common stock in exchange for each share of Foundry …
(CNN)-- Thirty states ... ago," Hamburg said. Genentech, which makes the antiviral drug known as Tamiflu Oral Suspension, had reported temporary delays in new shipments, but it is working with the FDA to release its reserve …
CNN5y
Author Disclosures: Mr Bott owns stock in Merck, Incyte, and Johnson & Johnson ... South San Francisco, CA: Genentech, Inc; 2013. accessdata.fda.gov/drugsatfda_docs/label/2013/021455s014s015lbl.pdf. Updated April 2013. …
Prior to that, you have to go back almost a decade, when Genentech raised $1.94 billion in its second ... pocketed nearly $20 million in cash and stock awards last year, while Alberto Martinez, the company’s president and chief operating …
[See: 9 Biotech Stock Funds to Buy.] But should you invest ... "Obviously there's a lot of risk, but if you look at companies like Vertex, Genentech and Amgen (AMGN) – they went public and took years to become profitable." Early in the game.